Skip to main content
OpenTrials
Completed

NCT Number: NCT00110630

Smoking Treatment of Prisoners

The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

About this study

This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1) current smoker and (2) seeking group treatment to quit smoking.

Exclusion criteria

  • (1) non-english speaking, (2) housed in segregation, (3) presence of active, severe mental illness as defined by active psychosis, manic episode, or imminently suicidal/homicidal, (4) mental retardation such that they cannot provide informed consent, and (5) due to be released or transferred to another facility within the next year.

Treatment and study plan

10-week smoking cessation group therapy combined with NicoDerm CQ

Behavioral

Primary outcomes

  1. smoking cessation

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • GlaxoSmithKline

Registry information

Official study title

Smoking Treatment of Prisoners: Project "STOP"

Acronym: STOP

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
May 11, 2005
Registry last updated
Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.